Sex Chromosome Disorders: Clinical Trials

273 trials for Sex Chromosome Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

154 completed, 41 recruiting, 30 unknown, 15 terminated. 62 Phase 2, 42 Not applicable, 29 Phase 3, 21 Phase 4, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 262Completed 41, Not yet recruiting 5, Recruiting 4, Active not recruiting 3, Terminated 3, Unknown 3, Suspended 2, Withdrawn 1
Not applicable42Completed 21, Recruiting 10, Unknown 4, Active not recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 329Completed 19, Active not recruiting 4, Recruiting 3, Terminated 2, Not yet recruiting 1
Phase 421Completed 15, Recruiting 5, Unknown 1
Phase 118Completed 12, Terminated 2, Enrolling by invitation 1, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow Sex Chromosome Disorders: new trials by email Literature Review of Sex Chromosome Disorders trials Research Report on Sex Chromosome Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS
Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD)
Phase 2 / Phase 3Not yet recruitingSpinogenix1202026-12-012026-10-09
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
SRX246, Placebo - Aggressive Behavior in Fragile X Syndome
Phase 2Not yet recruitingAzevan Pharmaceuticals802026-12-012026-10-30
Hematological Profile in Children With Numerical Chromosomal Disorders
Down Syndrome, Turner Syndrome
Not yet recruitingAssiut University1582026-11-022026-10-29
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
EMPOWER-ND - Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD)
Not applicableNot yet recruitingBoston University Charles River Campus502026-11-012026-10-27
Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control Study
Lipodystrophy Congenital Generalized, Lipodystrophy, Familial Partial
Not yet recruitingAssistance Publique - Hôpitaux de Paris14162026-10-012026-09-02
Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome
Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch - Turner Syndrome, Primary Ovarian Insufficiency
Phase 2Not yet recruitingChildren's National Research Institute152026-09-012026-08-25
The Neurocognitive Bases of Trust in Intellectual Disability
Confidence adjustment assessment, clinical assessment, Cognitive assessment - Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS)
RecruitingHospices Civils de Lyon1122026-07-172026-08-05
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Inpegsomatropin-Injection, Givopegsomatropin Solution Injection - Turner Syndrome
Phase 3RecruitingXiamen Amoytop Biotech Co., Ltd.842026-07-052026-07-22
A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies
Social Management Training - Sex Chromosome Disorders
Phase 1RecruitingUniversity of Oslo302026-06-012026-07-22
Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome
CTH120, CTH120 placebo hard capsules - Fragile X Syndrome (FXS), Fragile X Syndrome
Phase 2RecruitingConnecta Therapeutics, S.L.302026-05-212026-07-17
Optical Imaging in X-linked Disorders.
Clinical assessment, Parental questionnaires, Cognitive assessment - Fragile X Syndrome (FXS), Creatine Transporter Deficiency
Not applicableRecruitingHospices Civils de Lyon1182026-03-302026-05-15
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD)
RecruitingHealing Hope International1002026-03-012026-03-25
A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases
Oral estradiol valerate, Transdermal 17β estradiol - Turner Syndrome
Phase 2Not yet recruitingUniversiti Kebangsaan Malaysia Medical Centre242026-02-152026-02-02
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Lonapegsomatropin [SKYTROFA®], Somatropin Pen Injector - Turner Syndrome, Short Stature Homeobox Gene Mutation
Phase 3RecruitingAscendis Pharma A/S1862025-12-122026-09-30
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Low dose of MRM-3379, Middle Dose of MRM-3379, High dose of MRM-3379 - Fragile X Syndrome
Phase 2RecruitingMirum Pharmaceuticals, Inc.602025-11-222026-09-29
Parental Project Amongst 93 Patients With Turner Syndrome
Turner Syndrome
RecruitingUniversity Hospital, Strasbourg, France932025-11-182026-01-15
Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome
CBD Oral Solution, Placebo - Fragile X Syndrome
Phase 2RecruitingUniversité de Sherbrooke402025-09-012026-08-28
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Micronized progesterone 200 MG, Micronized Progesterone 100 MG - Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Phase 4RecruitingChildren's Mercy Hospital Kansas City402025-07-312026-08-25
Effect of CBD on the Brain
CBD Oral Solution (eCBD system Target), Placebo - Fragile X Syndrome
Phase 2Not yet recruitingUniversité de Sherbrooke502025-05-012025-02-17
Long-term Systematic Follow-up of Patients With Klinefelter Syndrome Followed at the Department of Growth and Reproduction, Rigshospitalet
There is no intervention, only clinical description - Klinefelter Syndrome
Enrolling by invitationCopenhagen University Hospital, Rigshospitalet3002025-04-012025-09-10

Showing 20 of 273. Sign in to see all of them.

Narrower conditions

Turner Syndrome (124)  ·  Fragile X Syndrome (114)  ·  Klinefelter Syndrome (47)  ·  Down Syndrome (23)  ·  Genetic Diseases, Inborn (20)  ·  Autism Spectrum Disorder (17)  ·  Intellectual Disability (16)  ·  Trisomy 13 Syndrome (14)  ·  Trisomy 18 Syndrome (14)  ·  Autistic Disorder (12)  ·  Dwarfism, Pituitary (12)  ·  Primary Ovarian Insufficiency (11)  ·  Dwarfism (10)  ·  Hypogonadism (9)  ·  Congenital Abnormalities (8)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (273)  ·  Chromosome Disorders (268)  ·  Congenital Abnormalities (265)  ·  Genetic Diseases, Inborn (253)  ·  Endocrine System Diseases (163)  ·  Female Urogenital Diseases (162)  ·  Female Urogenital Diseases and Pregnancy Complications (162)  ·  Urogenital Diseases (162)  ·  Male Urogenital Diseases (161)  ·  Gonadal Disorders (160)  ·  Urogenital Abnormalities (160)  ·  Sex Chromosome Disorders of Sex Development (156)  ·  Disorders of Sex Development (155)  ·  Nervous System Diseases (143)

Interventions

Human Growth Hormone (24)  ·  Growth Hormone (10)  ·  Estradiol (8)  ·  mavoglurant (6)  ·  Metformin (5)  ·  arbaclofen placarbil (5)  ·  BPN14770 (4)  ·  Blood Specimen Collection (4)  ·  Minocycline (4)  ·  gaboxadol (4)  ·  2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine (3)  ·  Acamprosate (3)  ·  Estrogens (3)  ·  Lovastatin (3)  ·  Ascorbic Acid (2)

Sponsors

University of Aarhus (17)  ·  Novo Nordisk A/S (12)  ·  University of Colorado, Denver (10)  ·  Children's Hospital Medical Center, Cincinnati (9)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (9)  ·  Seaside Therapeutics, Inc. (9)  ·  Stanford University (8)  ·  Natera, Inc. (6)  ·  Novartis Pharmaceuticals (6)  ·  University of California, Davis (6)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  Hospices Civils de Lyon (4)  ·  Merck KGaA, Darmstadt, Germany (4)  ·  Tetra Discovery Partners (4)  ·  Université de Sherbrooke (4)

Countries

United States (146)  ·  France (39)  ·  Denmark (31)  ·  Spain (27)  ·  Italy (21)  ·  Canada (17)  ·  United Kingdom (17)  ·  Germany (14)  ·  Netherlands (12)  ·  Australia (10)  ·  Belgium (9)  ·  South Korea (8)  ·  Sweden (8)  ·  Switzerland (8)  ·  Israel (7)

Top investigators

Elizabeth Berry-Kravis, MD, PhD (5)  ·  Randi J Hagerman, MD (4)  ·  Allan L Reiss (3)  ·  Bryan King, MD, PhD (3)  ·  Craig Erickson, MD (3)  ·  Craig Erikson, MD (3)  ·  Elizabeth Berry-Kravis, MD (3)  ·  James McCracken, MD (3)  ·  Jeremy Veenstra-VanderWeele, MD (3)  ·  Lawrence Ginsberg, MD (3)  ·  Linmarie Sikich, MD (3)

Results publications

PMID 36978128, PMID 26764156, PMID 26855682, PMID 32542985, PMID 33395098, PMID 35794169, PMID 10417280, PMID 10518081, PMID 10599727, PMID 10599729, PMID 11531930, PMID 12466334, PMID 12629094, PMID 12820840, PMID 15784709, PMID 15900109, PMID 16757526, PMID 16801584, PMID 16814942, PMID 17535868, PMID 17875973, PMID 19699898, PMID 20375405, PMID 20733274, PMID 20937127, PMID 21059347, PMID 21209411, PMID 21294891, PMID 21310373, PMID 21398400, PMID 21406078, PMID 21449786, PMID 21519036, PMID 21619701, PMID 21862226, PMID 21880799, PMID 21982653, PMID 22005709, PMID 22104675, PMID 22281937, PMID 22464072, PMID 22508317, PMID 22617594, PMID 22742782, PMID 22788856, PMID 23215555, PMID 23444191, PMID 23567489, PMID 23613152, PMID 23658497

NIH funding

UL1TR001082 (4), 2009 (3), K23HD109375 (2), 2004 (1), 2008 (1), 2023 (1), 2025 (1), 268201000048C-5-0-1 (1), K01MH083045 (1), K23HD092588 (1), K23MH077554 (1), K23NS070337 (1), N01HV681997 (1), R01AG076678 (1), R01HD071987 (1)